廣告
香港股市 已收市

  • 恒指

    17,651.15
    +366.61 (+2.12%)
     

  • 國指

    6,269.76
    +149.39 (+2.44%)
     

  • 上證綜指

    3,088.64
    +35.74 (+1.17%)
     

  • 滬深300

    3,584.27
    +53.99 (+1.53%)
     

  • 美元

    7.8281
    +0.0003 (+0.00%)
     

  • 人民幣

    0.9251
    +0.0008 (+0.09%)
     

  • 道指

    38,239.66
    +153.86 (+0.40%)
     

  • 標普 500

    5,099.96
    +51.54 (+1.02%)
     

  • 納指

    15,927.90
    +316.14 (+2.03%)
     

  • 日圓

    0.0492
    -0.0009 (-1.74%)
     

  • 歐元

    8.3707
    -0.0275 (-0.33%)
     

  • 英鎊

    9.7780
    -0.0140 (-0.14%)
     

  • 紐約期油

    83.66
    +0.09 (+0.11%)
     

  • 金價

    2,349.60
    +7.10 (+0.30%)
     

  • Bitcoin

    62,937.86
    -1,403.33 (-2.18%)
     

  • CMC Crypto 200

    1,314.19
    -82.35 (-5.89%)
     

Why Reata Pharmaceuticals Shares Are Falling Monday?

Vandana Singh
·1 分鐘文章

  • According to various reports, the FDA's neuroscience expert Billy Dunn is leaving the agency after more than 15 years, effective immediately.

  • Dunn presided over the controversial approval of Biogen Inc's (NASDAQ: BIIB) Alzheimer's disease treatment, Aduhelm (aducanumab).

  • Dunn, 53, is retiring from the agency to "explore other opportunities," according to an internal FDA email. Dunn notified agency officials Friday, according to a person with knowledge of the situation.

  • Reata Pharmaceuticals Inc (NASDAQ: RETA) shares are falling in reaction to the news as its marketing application seeking approval for omaveloxolone for Friedreich's ataxia is due on 28 February.

  • The FDA has already postponed the application after the company submitted additional data.

  • Friedreich ataxia is a rare inherited disease that causes progressive damage to your nervous system and movement problems.

  • Nerve fibers in your spinal cord and peripheral nerves degenerate, becoming thinner.

  • Price Action: RETA shares are down 35.7% at $28.61 on the last check Monday.

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

This article Why Reata Pharmaceuticals Shares Are Falling Monday? originally appeared on Benzinga.com

.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.